Nemaura Medical published its CY Q4 ’21 (FY Q3 ’22) business update (press release), though the company did not host an associated webcast with investors. Of note, the company only provided brief commentary on the launch of MiBoKo (view website) for employer groups and insurers/payers, the MySugarWatch DuoPack Limited deal, and the appointment of Dr. Arash Ghadar (view LinkedIn) as COO. Below are highlights from the press release.